Emerging opportunities in the viral vector manufacturing market include personalized medicine growth, expanded clinical trials, and regional manufacturing partnerships. Advances in bioprocessing and ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta Therapeutics announced that the US FDA has granted Platform Technology ...
OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’s ...
The AAV vector market is advancing due to the rising demand for gene therapies targeting disease causes at the cellular level ...
"We're not a one-size-fits-all CDMO," said Min Park, CCO of Matica Bio. "Our team works closely with each partner to deliver ...
IB [email protected] ReiThera to Showcase Innovative Viral Vector Platforms at ESGCT 2025Rome, Italy – September 30 2025 – ReiThera Srl, the Italian leading Contract Development ...
Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...
News-Medical.Net on MSN
PlasmidFactory and Fraunhofer IZI join forces to advance non-viral cell and gene therapies
PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback